-
Dallas County Young Adult Poverty Drops to 11% Amid Economic Mobility Efforts
-
Germany Thrash Netherlands 5-0 to Top Nations League Group
-
People Power Party Leader Jang Dong-hyuk Visits Han Dong-hoon’s Father-in-Law’s Funeral
-
Diljit Dosanjh Brings 'AURA India Tour' to Indore After Sold-Out Delhi Show
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
Samsung Galaxy S27 Series Camera Design Leaked via Lens Protectors
-
NexCore and MetLife Investment Management Launch $1.3 Billion Senior Living Co-Investment Venture
-
Galway Metals Intersects 1.8 g/t Gold Over 25.0 Metres and 0.7 g/t Gold Over 66.0 Metres at Clarence Stream
-
RuffleButts + RuggedButts Featured in Hasbro's 2026 Holiday Gift Guide
-
KIDZ AI Announces Strategic Collaboration with Synestria to Optimize AI Infrastructure Performance
-
Brightline Interactive and TruWeather Solutions Sign MOU to Bring Weather Data into SpatialCore Physical AI Platform
-
Avino Announces Key Technical Appointment
-
HippoFi Achieves OTCID Market Designation, Opening a New Chapter of Commercial Growth
-
Gabriel Resources Provides Corporate and Financing Update
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Pivotree Announces Third Quarter 2026 Results
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
How to Turn Your Garage into Usable Living Space
-
Glidewell Opens Applications for 2027 Guiding Leaders Cohorts in California and North Carolina
-
The Next Healthcare Story Worth Telling May Be About Someone You Know
-
NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
-
Atlas Signal Initiates Coverage of High Roller Technologies: ROLR(TM) Prediction-Markets Platform Goes Live on iPhone for U.S. Customers
-
Join Nord Precious Metals' Live Investor Webinar: Advancing Silver Production and High-Grade Exploration in Ontario
-
Executing Our Plan, Increasing Equity and Reducing Liabilities in Order to Build Long-Term Value
-
Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment
-
Nexscient Reports Third Quarter 2026 Results; Revenue Rises Sequentially as Gross Margin Expands to Over 40%
-
Viking Global Technologies Announces Expansion of Grid Protection Technology Pilot with Another Major U.S. Electric Utility
-
TRNR Reports Record Q3 2026 Results, Driven by 66% Revenue Growth; M&A Pipeline Grows Significantly
-
Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program
-
FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
-
Waste Energy to Host Shareholder Update Today at 4:30 PM EST; Management to Discuss WE #1 Commissioning, Revenue Opportunities and Growth Strategy
-
Klique Joins Lenovo AI Innovators, Bringing Its Enterprise AI Control Plane to Lenovo Hybrid AI Factory
-
Miami Allstars FC have Applied to Compete in the Women's Premier Soccer League, with the Club Targeting a 2027 or 2028 Debut in North Miami, Florida
-
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
-
International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital
-
Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
-
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027
-
Monaco Housing Project Wins International Sustainability Award at COP31
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
The Next Healthcare Story Worth Telling May Be About Someone You Know
AimwellBio invites patients, colleagues and healthcare organizations to nominate professionals for consideration in its 2027 editorial coverage.
MIAMI, FL / ACCESS Newswire / November 17, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, is inviting the public to nominate physicians, medical researchers, scientists and other healthcare professionals for potential features as it plans its 2027 editorial coverage.
A physician finds a better way to reach patients who struggle to access care. A researcher moves a promising line of inquiry forward. A community practitioner tackles a health need that has gone overlooked. Patients and colleagues often see the impact of this work firsthand, and AimwellBio wants to hear from them.
Who should be nominated?
AimwellBio welcomes nominations from clinical medicine, biotechnology, medical research, pharmacy, rehabilitation, preventive care, healthcare technology and other areas of healthcare. Patients, colleagues, academic institutions, healthcare organizations and professional associations may submit nominations. Self-nominations are welcome.
Tell us what the person did, who their work serves and why it deserves a closer look. Where available, include links to publications, professional credentials, projects or other publicly verifiable information that helps document the contribution.
Nominations do not guarantee selection, publication, endorsement or participation in AimwellBio's professional network. Potential features are subject to review and editorial approval.
How to submit a nomination
Email [email protected] with the subject line Healthcare Professional Nomination. Include the professional's name, specialty, location, a short description of their contribution and, if available, a relevant public professional link. Do not include confidential patient information or private medical records.
About AimwellBio
AimwellBio, operated by Aimwell Partners Inc. (OTCID:AIMN), is a healthcare intelligence platform focused on source-traceable information, professional verification and the evaluation of healthcare and biopharmaceutical intelligence. Its offerings include AI visibility assessments, professional information resources and intelligence tools for qualified healthcare and research audiences. aimwellbio.com
Forward-Looking Statements
This release contains statements concerning potential future professional features, editorial activities and participation opportunities. These statements reflect current intentions and expectations, involve uncertainties and are not guarantees of future results. The timing, scope and outcome of any future initiative may change. Nominations do not establish professional standing, clinical quality or endorsement by AimwellBio.
Media and nominations: AimwellBio | Aimwell Partners Inc. (OTCID:AIMN) | [email protected] | aimwellbio.com
SOURCE: Aimwell Partners
View the original press release on ACCESS Newswire
Y.Aukaiv--AMWN